Simvastatin improves fracture healing in mice

Area of Science:

• Orthopedics
• Pharmacology
• Bone Biology

Background:

• Statins are known to have anabolic effects on bone, potentially by activating bone morphogenetic protein (BMP)-2.
• Previous studies on statins and bone metabolism have yielded conflicting results, with a focus on osteoporosis.
• The efficacy of statins in accelerating fracture healing remains largely unexplored.

Purpose of the Study:

• To investigate the effect of simvastatin on bone fracture healing in a mouse model.
• To evaluate the impact of simvastatin on biomechanical properties and histological healing of femur fractures.

Main Methods:

• Femur fractures were surgically induced in 81 male BALB/c mice and stabilized with marrow-nailing.
• Mice were randomized to receive either a simvastatin-supplemented diet (120 mg/kg/day) or a control diet.
• Femurs were harvested at 8, 14, and 21 days post-operation for measurement of callus diameter, biomechanical testing (three-point bending), and histological analysis.

Main Results:

• At 14 days post-operation, simvastatin-treated mice exhibited a 53% larger fracture callus transverse area compared to controls (p=0.001).
• Biomechanical testing at 14 days showed a 63% increase in the force required to break the bone (p=0.001) and a 150% increase in energy uptake (p=0.0008) in the simvastatin group.
• While simvastatin increased callus size and strength, histological healing was complete by 21 days, and mechanical differences between groups diminished.

Conclusions:

• Simvastatin significantly enhances early bone fracture healing by increasing callus size and mechanical strength in mice.
• The observed effects suggest a potential role for statins in accelerating fracture repair.
• Further research is warranted to explore the clinical application of statins in fracture management.